Monoclonal antibodies obtained using rapamycin position 27 conjugates as an immunogen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 1, 2003
Issued Date -
N/A
app pub date -
Feb 2, 2001
filing date -
Apr 23, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Provided are rapamycin conjugates which are useful as immunogenic molecules for the generation of antibodies specific for rapamycin or a derivative thereof, for measuring levels of rapamycin or derivatives thereof; for isolating rapamycin binding proteins; and detecting antibodies specific for rapamycin or derivatives thereof. This invention also provides monoclonal antibodies specific for rapamycin or a ring opened derivative of rapamycin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully